5:18 PM
 | 
Feb 14, 2014
 |  BC Extra  |  Financial News

Regimmune raises $9.2 million in series D

Autoimmune and allergy company Regimmune Corp. (Tokyo, Japan) raised $9.2 million in a series D round led by Japan Asia Investment and Nippon...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >